Pure Global
Registrant profile

Wuhan Life Origin Biotech Joint Stock Co., Ltd.

武汉生之源生物科技股份有限公司
Hubei·China NMPA·207 registered devices
207
Total devices
2
Device classes
2018
Earliest approval
2024
Latest approval
Company overview
Total devices
207
Province/Region
Hubei
湖北
Address
1st, 2nd and 3rd floor, No. 818 Gaoxin Avenue, Wuhan East Lake New Technology Development Zone, No. 818 High-tech Medical Equipment Park
武汉东湖新技术开发区高新大道818号高科医疗器械园B11号1楼、2楼、3楼
Registration timeline
Earliest approval
Aug 30, 2018
Latest approval
Dec 26, 2024
Device class distribution
Breakdown of 207 devices by regulatory classification
Class II
205
99.0% of total
Class III
2
1.0% of total
Registered devices (10 most recent shown)
Click on any device for detailed registration information
Product nameClassRegistration numberApproval dateExpiry dateDetail
Fully automatic chemiluminescence immunoassay analyzer
全自动化学发光免疫分析仪
Class II鄂械注准20242225327Dec 26, 2024Dec 25, 2029View
Retinol Binding Protein Control
视黄醇结合蛋白质控品
Class II鄂械注准20242405165Sep 04, 2024Sep 03, 2029View
Retinol binding protein calibration solution
视黄醇结合蛋白校准品
Class II鄂械注准20242405162Sep 02, 2024Sep 01, 2029View
Retinol binding protein determination reagent kit (latex immunoturbidimetric assay)
视黄醇结合蛋白测定试剂盒（胶乳免疫比浊法）
Class II鄂械注准20242405161Sep 02, 2024Sep 01, 2029View
Creatinine calibration product
肌酐校准品
Class II鄂械注准20242405096Jul 25, 2024Jul 24, 2029View
Creatinine assay kit (creatine oxidase method)
肌酐测定试剂盒（肌氨酸氧化酶法）
Class II鄂械注准20242405097Jul 25, 2024Jul 24, 2029View
Fully automatic chemiluminescence immunoassay analyzer
全自动化学发光免疫分析仪
Class II鄂械注准20242225041Jun 27, 2024Jun 26, 2029View
Cystatin C quality control material
胱抑素C质控品
Class II鄂械注准20242405012Jun 06, 2024Jun 05, 2029View
Cystatin C determination reagent kit (latex immunoturbidimetric method)
胱抑素C测定试剂盒（胶乳免疫比浊法）
Class II鄂械注准20242405013Jun 06, 2024Jun 05, 2029View
Cystatin C calibration solution
胱抑素C校准品
Class II鄂械注准20242405014Jun 06, 2024Jun 05, 2029View
About this profile

Complete regulatory portfolio for Wuhan Life Origin Biotech Joint Stock Co., Ltd. in China's medical device market. This registrant has 207 medical devices registered with China NMPA, with registrations dating from Aug 30, 2018 to Dec 26, 2024.

Browse the complete device portfolio including device classifications, registration numbers, approval dates, and technical specifications. Pure Global AI provides free access to comprehensive China NMPA registration data, helping global MedTech companies analyze market presence and regulatory compliance for Chinese medical device manufacturers.